![]() Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | ![]() Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | ||
Founding Date | Founding Date 2009 | Founding Date 1980 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US |
Employees | Employees 3,9671% decrease | Employees 25,200 | Employees 1091% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) $111.9m (FY, 2017) |
Net income | Net income N/A | Net income $7.7b (FY, 2025) | Net income ($437.1m) (FY, 2017) |
Operating ⚠ | |||
Patents (US) | Patents (US) N/A | Patents (US) 31 (FY, 2020) | Patents (US) 72 (FY, 2016) |
Funding | |||
Total funding raised | Total funding raised $ 85.3m | Total funding raised N/A | Total funding raised $ 310m |

Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company